Test for early diagnosis of neurodegenerative diseases

Foto-MACorrea-CSpuch-equipo-rec

The CINBIO group, TNT, which develops nanostructures, led by Miguel Ángel Correa, together with researchers from Chuvi (Hospital Complex of the University of Vigo), part of the Instituto de Investigación Sanitaria Galicia Sur (IISGS), have patented a procedure, using nanoparticles surrounded by antibodies, to diagnose in blood the presence of eleven proteins related to alzheimer, depression and multiple sclerosis. The cost of this chip would be very small compared to the high value of an early diagnosis of these neurodegenerative diseases, for a more effective treatment.

Click here to go to the information of Faro de Vigo.